about
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) huma...
Read More
1.94
-0.03
(-1.52%)
29,620
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for VivoSim Labs Inc. is on 14 Jul 2025 for the purpose of VivoSim Labs Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
VivoSim Labs Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..